What was once expensive and revolutionary-full-genome sequence-is now affordable and routine. Costs will continue to drop, opening up new frontiers in behavioral genetics. This shift in costs from the genome to the phenome is most notable in large clinical studies of behavior and associated diseases in cohorts that exceed hundreds of thousands of subjects. Examples include the Women's Health Initiative (www.whi.org), the Million Veterans Program (www.research.va. gov/MVP), the 100 000 Genomes Project (genomicsengland.co.uk) and commercial efforts such as those by deCode (www.decode.com) and 23andme (www.23andme.com). The same transition is happening in experimental neuro-and behavioral genetics, and sample sizes of many hundreds of cases are becoming routine (www.genenetwork.org, www.mousephenotyping.org). There are two major consequences of this new affordability of massive omics datasets: (1) 
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| INTRODUCTION
Genetic analysis of behavior has involved two competing and almost antithetical approaches. The older of the two, sometimes called forward or classical genetics, starts with interesting and heritable differences in behavior among individuals and attempts to define gene loci, sequence variants and systems that contribute to these differences (reviewed in References 1, 2 ). Quantitative trait locus (QTL) mapping and genome-wide association studies (GWASs) are common examples of this systematic downward approach-from differences in behavior to a subset of causal loci, haplotypes, alleles or even specific DNA variants. The other approach, sometimes called reverse genetics (although upward makes more sense), starts with defined sequence differences or mutations (knockouts, knock-ins, transposon or transgene insertions) and then works from the polymorphism up through molecular and cellular cascades that influence (but rarely determine) brain function and behavior. [3] [4] [5] The two communities of researchers have worked back-to-back on many of the same problems for years; often without listening to each other. On the one hand, the forward genetics community enthusiastically uses ever more sophisticated methods to fine-map multitudes of variants with small effects on behavior (reviewed in Reference 1 ). 6 On the other hand, the reverse genetics community enthusiastically uses ever more sophisticated molecular methods to modify DNA sequence and define the impact on behaviors-almost always on a single genetic background. Both approaches build causal models, but the forward method has the advantage of direct relevance to natural populations and common sequence variants that are responsible for most human neurological and psychiatric disease. The reverse method has the advantage of much more direct linkage to mechanism.
Over the past decade forward and reverse approaches have begun to merge, and are now happy partners thanks to highthroughput genomic methods, in particular genome and transcriptome sequencing. One example of the hybridization of these two methods is that the final phase of QTL mapping now involves an almost obligatory analysis of sequence variants of large numbers of candidate genes. Polymorphisms with high potential biological impact (eg, missense and nonsense mutations) rank well as candidates. In effect, the last stage of QTL mapping now involves a reverse genetic assessment. There are many other interesting ways that genomics and transcriptomics are changing the landscape of behavioral neurogenetics, as well as the analysis of neurological and psychiatric diseases. Here, we provide several examples of the impact that highthroughput omics is having on our field. We are now able to ask and answer questions using new methods. While we focus on mouse models, there are almost always direct applications of these same methods to other species, and more specifically, to human populations.
| RESULTS AND DISCUSSION

| QTL mapping of behavior using sequence data
As mentioned above, the analysis of genome sequence data is now almost an obligatory last step of QTL analyses. [7] [8] [9] [10] . After a QTL has been mapped with sufficient precision (a topic to which we return), it is necessary to sort through and evaluate the strength of candidates within the 1.5-2.0 LOD confidence interval based on numbers and types of sequence variants in each locus or gene or conserved element in a particular population or cross. While an interval may be large, encompassing hundreds of genes, if we are highly confident that there are no sequence variants in or around those genes, we can discount (not eliminate) their causal role. While those of us who map for a living obsess about the size of our QTL confidence intervals with the goal of obtaining down to 1 Mb or less, this is actually an old-fashioned metric. 11 A much more important metric in a postsequence world is the number of genes and classes of sequence variants within an interval, almost irrespective of its absolute length. For example, using reduced complexity crosses (RCCs), it is practical to "clone" causal variants with a QTL that is formally well over 10 Mb in size (see section below, References 12, 13 that predicts obesity risk is apparently a variant within an enhancer that affects expression of the neighboring IRX3 transcription factor.
14 While we have highlighted these analytic complexities, our own perhaps premature impression is that problems of these types will be comparatively infrequent. Further, as we learn more about the functional impact of control elements in the genome and the complex configuration of chromatin loops, it should become possible to rank even these intergenic and intronic variants with better assurance.
To summarize this section: the last steps in QTL mapping are dependent on sequence data. Once an interval has been defined, the analysis quickly takes on the character of reverse genetics, evaluating potential biological impact of particular variants. However, unlike genetically engineered knockout lines and transgene insertions, there is usually a large set of polymorphisms that are causal contenders. This is why large-scale genetic and omics datasets for multiple species, diseases, organs and cells 9, 15, 16 are so valuable in efficient evaluation of the candidacy of genes in any interval.
Finally, there really are no longer any limitations as to the type of cross or population or species that will benefit from sequence data. highly polymorphic in crosses between the parental strains-C57BL/ 6J (B for short) and DBA/2J (D for short). The problem is that while we can easily look up phenotypes and "reverse map" them to the C15orf52 region using the large assemblage of BXD phenotypes, it will be hard to attribute function strictly to the D nonsense mutation in C15orf52. Let's try this anyway.
Step 1. Find a SNP located close to the mutation that has been genotyped in all of the BXD strains. SNP rs27440124 is a good choice and will be used as a positional surrogate for the actual mutation.
Step Step 3. We now use the forward methods to affirm that the Gto-P correlation is associated with a significant QTL. This is not really necessary, but one point of this article is to make it clear that reverse and forward methods are merging. 23 25 hemoglobin concentration). If we were to exploit genetically modified animals in the next phase of work, it would make good sense to also check these phenotypes.
Genetics studies of brain and behavior are gradually becoming larger and more systematic. In the case of genome-wide studies of human behavioral diseases, sample size is king, and studies now are creeping up from tens of thousands to millions. The driver for this process is the small effect sizes of most sequence variants on behav- however, this will require larger sample sizes to maintain power.
Over the next 50 years we are going to rapidly need to become comfortable with whole-phenome analysis if we expect to make genuine progress toward predictive (aka precision) health care. But there have been at least a few notable successes in aggregating large phenome collections for specific cohorts and crosses of both human and mouse.
5,26,27
2.3 | Behavioral analysis coupled to wholetranscriptomes, whole-epigenomes and other "omes"
In the previous section, we describe how sequencing technology can be used to link sequence variants at the whole-genome level with phenotypes. However, we need to understand how these variants alter the phenotype. It is not only important to find linkage between genomic variants and phenotypes, but we also need to understand the biological networks between levels of analysis. In this section, we outline some of the ways in which sequencing technologies have been used to tackle this problem, and how they could be used in the future.
Many of the significant GWAS hits that have been found in humans have been in noncoding regions [28] [29] [30] [31] -sites which are unlikely to alter the sequence of a protein product, but are much more likely to alter gene expression or isoform use: either how much, where or when different versions of a protein are expressed.
Microarrays have traditionally been used to examine mRNA expression, 9,15,32 but RNA-seq has now become the method of choice for many investigators (reviewed by References 33, 34 ). We may give the impression here that microarrays are an obsolete technology, which has been overtaken by sequencing but this is not the case, as in a number of situations microarrays can be preferable: they are quick, cheap and bioinformatically very easy to interpret. RNAseq is not without its challenges and problems, but offers several unique advantages over microarrays. [35] [36] [37] [38] [39] For example, RNA-seq includes genotype data, and therefore can be used to identify allelic imbalance, 40 , parent-of-origin effects and imprinting. 41 For expression microarrays, the sequence of the RNA of interest should ideally be known. Generating accurate transcriptome data is difficult in individuals for whom potential sequence variants are undefined. This is exemplified in several studies, 39, [42] [43] [44] that have
shown how sequence variants (as found by genomic sequencing), altered the apparent expression levels (ie, because of poor hybridization or sequence alignment due to previously unknown SNPs). Therefore, one potential advantage of RNA-seq over arrays for linking gene expression and behavioral phenotypes is that it allows testing of wild type and wild-type derived populations (eg, the Collaborative Cross), but even here it is important to ensure that the alignment procedure is not confounded by sequence differences and the sole use of a "canonical" genome assembly. Again, the solution is simply to sequence the genome of a subset of cases to produce a smart genome assembly that incorporates variants. Done properly, RNAseq and related methods are beginning to enable the analysis of a broader range of behaviors in natural populations. This also introduces new challenges: wild-derived populations do not behave in the same way as inbred or domesticated laboratory populations. For example, wild-derived animals show climbing behavior during the tail suspension test, something which is rarely seen in traditional laboratory strains. 45, 46 Gene expression data and many other molecular datasets can be treated as microphenotypes, and QTLs can be mapped in much the same way as described above for behaviors, enabling us to identify relations between variants and expression. When these expression- used genome, transcript, methylation and histone data in combination, finding many novel links between the different levels of regulation. They were able to show that the minor allele of rs3774937, associated with increased risk of ulcerative colitis, increased the expression of NFKB1 in cis, and that this increased NFKB1 bound elsewhere in the genome, decreasing DNA methylation at those sites and therefore causing trans-mQTLs. 57 As they acknowledge, their information about methylation is sparse, due to the use of microarrays, and therefore the use of methylation sequencing would allow the further elucidation of these complex biological interactions. Additionally, being able to make these associations relied on ChIP-seq data, showing that whole-epigenome sequencing could offer exciting insights into the regulation of phenotypes.
We have shown evidence of the advantages of wholetranscriptome and whole-epigenome analyses above, how these have been used, and are confident that these will become commonplace.
Further, new methods such as whole-proteome and wholemetabolome analyses are coming closer to fruition, which will allow an additional layer of biology to be put on top of these, bringing us nearer to the final behavioral phenotype. Proteomics is being significantly supported by the availability of genome and transcriptome data, acting as references for potential proteins, and many of the challenges are being overcome (reviewed by Reference
58
). Proteomics is already being carried out in the BXD population with integrated RNA-seq, 59 and this approach is ripe to be applied to behavioral phenotypes. B6 substrains are used for medical research worldwide. Separation of colonies at independent and isolated facilities has occurred since the 1950s and led to fixation of colony-specific genetic muta- substrains in order to identify a missense mutation in the Cyfip2 gene that drives substrain differences in binge eating 66 and the behavioral response to cocaine. 13 This approach has also been used to identify a gene variant driving differences in alcohol consumption in inbred selected rat lines. 71 Advances in sequencing now facilitate the RCC approach for any species for which substrains or nearly isogenic lines are available. Of course, there are caveats with the use of these and other isogenic or inbred lines that result from >100 years of domestication. Inbreeding and maintenance under laboratory conditions results in a loss of allelic and phenotypic diversity. 72 Therefore, they may not express the full range of phenotypes seen in the wild population, for example, activity and aggression are often reduced in domesticated population, 73 although there is some evidence of greater extremes of behavior in inbred lines. 74 The recipe for a successful RCC design (see Reference The genotyping strategies in step 4 are an essential part of the design of RCC experiments, and this is the step that has been greatly facilitated by the ease of generating high quality genomes and com- 
| Genotyping strategies
| Frontiers in behavioral genetics and the impact of sequencing 2.6.1 | Social genetics
The focus thus far has been on direct genetic effects (DGEs): the effect of an individual's genotype on the same individual's phenotype. 79 However, social genetic effects, also known as indirect genetic effects (IGEs), have become increasingly recognized. [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] Social genetic effects refer to the genotype of one individual altering the phenotype of a second individual, and these effects are notable in any group of interacting individuals. 83 For a social genetic effect to occur, the focal phenotype must be plastic in response to the interacting individual's phenotype 90 and this indirect effect must have a genetic basis. 89, 91, 92 Social genetic effects are not just important for understanding the behavioral phenotype of an individual, but also for the evolution of behaviors, as they represent an environment which is composed of litters, whereas the genotype of the offspring was differed (different lines of the BXD population). Therefore, any variation in the behavior of the mothers could be mapped to the genotype of their foster offspring. In both of these experimental designs, it has been shown that for some phenotypes, social genetic effects can explain more of the phenotypic variation than DGEs. 133, 141 We hope that we have now hammered home that social genetic effects are important and require careful consideration. The literature above has shown that social genetic effects can influence phenotypes due to cage mates, 133 maternal care 140 and early life sibling interactions, 141 and therefore potentially influence every study performed in model organisms. In most lab experiments the social genetic effect is thought to be included in the variance due to cage or litter effects; however, Baud et al 133 showed that modeling cage effects does not completely mitigate the social genetic effects. In inbred lines, it is not strictly possible to distinguish between a QTL due to DGEs or social genetic effects: the mother and siblings are the same genotype, and therefore any QTL mapped in the focal individual could in fact by due to a social genetic effect of mother or sibling.
We should emphasize that phenotypes here include gene expression and methylation: no phenotypic level is immune to this, and therefore it may have an unrecognized influence on sequencing data.
We will give a few examples of how the social genetic effect studies above could be extended to a whole-genome level. We have previously shown that cross-fostering can be used to investigate maternal, offspring and sibling effects during early life 140 : the technique is described in depth in Ashbrook & Hager 104 and this could be extended into later life phenotypes, or, for example, transcriptome mapping. It has been clearly showed that differences in maternal care
can influence offspring behavior and gene expression during adult life, [142] [143] [144] but identification of genetic variants in mothers that can then be directly associated with offspring adult gene expression or behavior has not, yet, been carried out.
The cohousing design of Baud et al 133 could be extended such that the genotype of one cage-mate is constant in all experiments, and the genotype of the second cage-mate is different in each experiment. Therefore, differences in the phenotype of individuals of the constant genotype will be due to differences in the genotype of their cage-mates, and these can be mapped to the genome. The low cost of sequencing means that this can now, potentially, be carried out in any population. A further step beyond this would be to map "epistasis between genomes." The phenotypic outcome of a social genetic effect is not just dependent on the genotype underlying the social genetic effect, but also on the genotype of the individual displaying 
| Forward and reverse behavioral genetics of wild populations
As described above, NGS has allowed the sequencing of wild populations as it does not require the genotype to be known in advance, as microarray methods do, although having a reference genome for a related species certainly makes the process easier. The availability of long-read sequences vastly improves our ability to assemble new genomes, and new technologies, such as PacBio and Nanopore, are now able to give reads between 100 and 1000 kilobases, an order of magnitude longer than current Illumina sequencing. 146 Combining these new technologies with "traditional" short-read NGS will greatly improve our ability to assemble de novo genomes (see, for example, Reference 147 for a de novo assembly of a large mammalian genome).
With this revolution in sequencing it will again be the phenotype which becomes important. Here, we highlight a few examples of "wild," or at least nonmodel, populations and how they are now being used for behavioral genetics. shows that new sequencing technologies can be used to investigate behaviors in nonmodel organisms, and give insight into the evolution of behavioral traits, which may not be amenable to study in model organisms. In a closely related species, P. leucopus, a combination of next-generation genomic-sequencing and transcriptomic-sequencing was used to show that transcriptomics could be carried out in a wild population without a reference genome, 150 again giving insight into evolution, and into the divergence of populations.
In foxes, Vulpes vulpes, GBS was carried out by Johnson et al 151 to determine the genetic architecture of tameness and aggressiveness, in a long-term study of domestication. They were able to detect QTL and candidate SNPs for this important feature of domestication, a process that comes with a wide-variety of behavioral adaptations. It also clearly shows how a genomics aspect is now being added to many behavioral studies, and can be potentially added retrospectively to add value to already long-running experiments.
Another species long studied, but that has only recently been the subject of genomic analyses is the domestic dog (Canis lupus familiaris). Sequencing has been used to examine a range of behaviors from stereotypically canid behaviors, such as pointing, 152 to behaviors which may give insight into human disorders, such as obsessivecompulsive behavior. 153 Under the common assumption that similar behavioral phenotypes have a similar genetic basis across species (a subject we come back to), these obsessive-compulsive behaviors could be of interest for obsessive-compulsive disorder, and the aggression-related genes in foxes could be of interest for antisocial personality disorder.
All of these studies are individually important for the behavior studied; however, the SNPs discovered and the transcriptome constructed can be applied to other studies in that species, as long as data are openly shared. For example, future studies in Peromyscus species now have reference genomes and transcriptomes, as well as known genetic polymorphisms, meaning that every sequencing study carried out increases our knowledge of the species as a whole.
| Behavioral genetics, brain structure and connectome
In the bulk of this review we have concentrated on cellular and subcellular phenotypes, such as gene and protein expression, as intermediates between genetic variation and behavior. However, cellular changes do not influence behavior in isolation. Behavior is the outcome of the integration of activities of many cells, synapses and hormones of different types working together in brain and body.
Polymorphisms that influence structure or connectivity are necessary to understand behavior, and especially pathological behavior. 154 Recent developments in imaging technologies [155] [156] [157] have made it possible to image in large numbers of living subjects, allowing novel insight into the link between genes, brain and behavior.
Natural variation in the size and connectivity of brain structure are heritable traits and thus can be mapped in the same way as the behavioral traits described throughout this review. We are beginning to understand the genetic architecture of subcortical brain structure in both mouse 158 and human, 156,159-161 with individual genes being identified which influence the volume of subcortical areas. Similar to many other phenotypes, it has been found that individual genomic variants have only a small impact on the total variation in brain structure size, and so large consortia have been established for the meta-analysis of brain imaging GWASs, such as the ENIGMA consortium. 161, 162 Connections between these physiological changes and behavioral, especially pathological, phenotypes are being made ( 160, 161, 163, 164 173 White et al were also the first to take the next step: identifying how genetic mutations altered the connectome, and therefore altered behavior. [173] [174] [175] They showed that a specific mutation in C. elegans altered synaptic input to a specific subset of motor neurons, and therefore specific changes to locomotor behavior. 175 The connectivity between brain regions has being increasingly used to investigate the pathology of brain disorders, the symptoms of which include behavioral changes. [176] [177] [178] which can be applied with minimal differences in both model organisms and humans, the argument being that it allows us to distinguish between homologous and analogous behaviors (ie, behaviors which are inherited from a common ancestor, and similar behaviors which have developed independently 184 ). A number of previous attempts have been made to find shared genetic influences on phenotypes which are analogous in model organisms and human 5, [185] [186] [187] [188] [189] [190] [191] ; however, these have not specifically tested if traits are homologous.
With genomic sequencing's ability to give us precise resolution of homology among genomes, we can now move on to precise resolution of homology among phenotypes.
One of the first to do this were Nithianantharajah & Grant 184 and Nithianantharajah et al, 192 who used touchscreen approaches to analyses cognitive domains in both mouse and human. They have the advantage that a battery of tests can be carried out in the same environment, with minimal experimenter contact, providing standardization and robustness. 184 They were able to show that subjects with a DLG2 mutation, which has been associated with schizophrenia, and mice with a Dlg2 mutation have a strikingly similar cognitive profile, which is distinct from mice carrying mutations of Dlg2 paralogues.
192
The approach is, therefore, cross-species reverse genetics, and as such would not be possible without genomic sequencing. This highthroughput "aligned mouse-human touchscreen battery," combined with high-throughput NGS could allow the rapid identification of homologous variants underlying homologous disease relevant phenotypes.
Earlier studies had been designed to try and developed human equivalents to traditional animal paradigms, for example, human ver-
sions of the open-field test 193, 194 and Morris water maze. 195 This approach has been described as "reverse-translational," because they were developing a human model of rodent behavior. 196 Although these initial studies did not carry out genetic analysis, it should be clear how their paradigms could be used for genetic screening, as motor and exploratory behavior can be noninvasively examined, and combined with genomic data from the human and mouse subject to find homologous genes associated with homologous behaviors.
One consideration here is the difference between innate (those which arise spontaneously, or are instinctive; such as exploratory behavior above) and learned behaviors (eg, the behaviors taught in touchscreen tests). We may perhaps assume that innate behaviors are under greater genetic control, as they arise spontaneously, whereas learned behaviors are not just dependent upon the individual's ability to perform the task, but also their capacity and motivation to learn, which in turn can be influenced by the environment.
However, it is not the case that innate behaviors are easier to map, due to these behaviors often being vital to the survival of the organism. Therefore, these traits are well buffered with no individual variant having a large effect, as they would be quickly selected against (imagine a variant that significantly disrupted feeding or mating behavior).
The ability to map variants underlying differences between innate and learned behaviors will depend on the experimental design:
a well-controlled laboratory experiment, where great care has been taken to minimize environmental variables will have greater power than a measurement in a wild population, where confounding variables could not be measured, independent of the difference between learned and innate behaviors. Take, for example, touchscreen tests which often provide phenotypes for which environmental effects can be minimized, delivering "clean" traits which can be efficiently mapped. 184, 197 Theoretically, large phenome datasets in either models or humans may provide us with the ability to test the assumption of dif- animals using a range of diets, pharmaceuticals and supplements. Fortunately, they had the foresight to save tails, and the genetic component is now being bolted on at a cost of about $20/animal-a bargain given the cost of obtaining longevity data. The same is also true for the Framingham Heart Study (www.framinghamheartstudy.org) that began as an epidemiological analysis of heart disease, but which in its third generation has become a major genetics and genomics study with sequence data for approximately 4000 subjects (www.nhlbiwgs.org/ group/fhs).
3.2 | We will soon have comprehensive catalogs of common and rare sequence variants of all types for many species
This is already almost true now for human, mouse and drosophila. In the case of human, it is possible to browse a first draft list of~85 million short variants segregating in~2500 sequenced humans from 26 different groups (http://phase3browser.1000genomes.org). In the case of clinicalgenome.org). Even a novice will soon be able to extract a list of intriguing missense variants (common or rare) in any gene or protein domain in humans and several model organisms. It will also soon be practical to extract lists of sequence variants (long and short) that affect epigenetic state expression level, and splicing of transcripts. From the geneticist's perspective we will be able to see the tips of the roots of causality. Whether we can understand the networks that produce the many leaves of phenotypes is an open question.
| The phenome is a mess
There really can be no argument: the phenome is central to the future of biology and what we audaciously or presumptuously call precision medicine. But the study of phenomes for any organism is still a backwater of a backwater. This is true in both model organisms and humans: behavioral phenotypes are measured with different methods, and yet still given the same name; disorders in humans, especially psychiatric disorders, can have very different symptoms and yet are lumped together. While we have become good at identifying homologous genes and variants across species, we struggle much more at identifying homologous phenotypes. While we will soon have complete and precise genomes, the next and much harder step will be to gain complete and precise phenomes.
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